These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15362083)

  • 21. Use of lithium in the adult populations of Denmark, Norway and Sweden.
    Bramness JG; Weitoft GR; Hallas J
    J Affect Disord; 2009 Nov; 118(1-3):224-8. PubMed ID: 19249102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paternal exposure and counselling: experience of a Teratology Information Service.
    De Santis M; Cesari E; Cavaliere A; Ligato MS; Nobili E; Visconti D; Caruso A
    Reprod Toxicol; 2008 Sep; 26(1):42-6. PubMed ID: 18598753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.
    Faber A; Bouvy ML; Loskamp L; van de Berg PB; Egberts TC; de Jong-van den Berg LT
    Br J Clin Pharmacol; 2005 Dec; 60(6):641-7. PubMed ID: 16305589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug related problems identified by European community pharmacists in patients discharged from hospital.
    Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
    Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of drug-interaction alerts in community pharmacies.
    Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heavy consumers of drugs--seen from the viewpoint of the community pharmacist].
    Mellbye KS; Berg C
    Tidsskr Nor Laegeforen; 2004 Dec; 124(23):3069-71. PubMed ID: 15586191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How many antibiotic prescriptions are unsubsidised in New Zealand?
    Norris P; Funke S; Becket G; Ecke D; Reiter L; Herbison P
    N Z Med J; 2006 May; 119(1233):U1951. PubMed ID: 16680168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the dispensing practices of drug retail outlets in selected towns, north west Ethiopia.
    Abula T; Worku A; Thomas K
    Ethiop Med J; 2006 Apr; 44(2):145-50. PubMed ID: 17447377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent.
    Hjardem E; Hetland ML; Østergaard M; Krogh NS; Kvien TK;
    Ann Rheum Dis; 2005 Aug; 64(8):1220-3. PubMed ID: 15640272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Filled prescriptions of age-related contraindicated drugs in children: a one-year nationwide cohort study in the Netherlands.
    Cheung K; Teichert M; Moll HA; Stricker BH; Visser LE
    Int J Clin Pharm; 2018 Oct; 40(5):1137-1143. PubMed ID: 30136053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does uncollected medication reduce the validity of pharmacy dispensing data?
    Tobi H; van den Heuvel NJ; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):497-500. PubMed ID: 15269934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information.
    Schirm E; Monster TB; de Vries R; van den Berg PB; de Jong-van den Berg LT; Tobi H
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):173-9. PubMed ID: 15072117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polypharmacy estimated by means of a population-based prescription database].
    Bjerrum L; Rosholm JU; Hallas J; Kragstrup J
    Ugeskr Laeger; 1999 Nov; 161(46):6355-9. PubMed ID: 10611835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database.
    Fredheim OM; Skurtveit S; Moroz A; Breivik H; Borchgrevink PC
    Acta Anaesthesiol Scand; 2009 May; 53(5):627-33. PubMed ID: 19419357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones.
    Wogelius P; Nørgaard M; Gislum M; Pedersen L; Schønheyder HC; Sørensen HT
    Int J Antimicrob Agents; 2005 Oct; 26(4):323-6. PubMed ID: 16144758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Referral and treatment patterns for complex regional pain syndrome in the Netherlands.
    DE Mos M; Huygen FJ; VAN DER Hoeven-Borgman M; Dieleman JP; Stricker BH; Sturkenboom MC
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):816-25. PubMed ID: 19388890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.